Education
About Us
Working with TipRanks
Follow Us
Pulmonx (LUNG)
NASDAQ:LUNG
Earnings Data
Report Date
May 05, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.33Last Year’s EPS
-0.36Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call highlighted several meaningful positives — a strengthened balance sheet via a $60M credit facility, a >10% cost restructuring, guidance for a ~30% reduction in cash burn, improved gross margins, accelerating enrollment in the AeriSeal pivotal trial (potential ~20% TAM expansion), and quarter-over-quarter improvements in loss metrics. However, material near-term challenges remain: Q4 worldwide revenue declined 5% (U.S. down 11%), sales force turnover (roughly half the team) disrupted U.S. execution, China shipments and registration timing create first-half 2026 headwinds, and full-year revenue guidance implies essentially flat top-line growth. Management expects recovery in the back half of 2026 and double-digit global growth by Q4 2026 if execution holds. Overall, positives around financial flexibility and cost discipline are balanced by persistent revenue execution risks, particularly in the U.S. and China.Company Guidance
Refinanced Debt and Strengthened Balance Sheet
Closed a $60 million credit facility with a 5-year interest-only structure (initial $40M drawn to refinance prior loan; $20M incremental optional draw through 2027 subject to revenue milestones), extending debt maturity to 2031 and increasing financial flexibility.
Cost Restructuring and Lower Cash Burn
Executed cost restructuring reducing ongoing operating expenses by over 10% and guiding to a decrease in annual cash burn from $32M in 2025 to $23M in 2026 (nearly 30% reduction). Full year 2026 operating expense guidance $113M–$115M (inclusive of ~$21M stock comp) and excluding stock comp implies a 7%–9% decrease versus 2025.
Improved Gross Margin and Expense Controls
Q4 2025 gross margin improved to 77.6% from 74% prior year (FY gross margin 74%); Q4 operating expenses decreased 11% YoY to $27.4M (excluding stock-based comp down ~10%), reflecting implemented cost controls (notably lower SG&A in Q4: $22.9M vs $27.0M prior-year quarter).
International Full-Year Revenue Strength
Full year 2025 international revenue of $33.5M, up 23% YoY (19% on a constant currency basis); Q4 international revenue $8.5M, up 8% YoY (2% cc), driven by strength in major European markets.
Clinical Program Progress — AeriSeal (CONVERT II)
CONVERT II enrollment momentum accelerating after clinical leadership changes; enrollment expected to complete in 2027. Management estimates potential to expand total addressable market by ~20% globally if successful.
Improved Quarterly Profitability Metrics
Q4 2025 net loss narrowed to $10.4M ($0.25/share) from $13.2M ($0.33/share) prior year; Q4 adjusted EBITDA loss improved to $5.5M from $7.5M a year ago. Added 10 new U.S. treating centers during the quarter.
LUNG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LUNG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 04, 2026 | $1.44 | $1.61 | +11.81% |
Nov 12, 2025 | $1.96 | $1.59 | -18.88% |
Jul 30, 2025 | $3.15 | $1.84 | -41.59% |
Apr 30, 2025 | $4.83 | $3.77 | -21.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pulmonx (LUNG) report earnings?
Pulmonx (LUNG) is schdueled to report earning on May 05, 2026, After Close (Confirmed).
What is Pulmonx (LUNG) earnings time?
Pulmonx (LUNG) earnings time is at May 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LUNG EPS forecast?
LUNG EPS forecast for the fiscal quarter 2026 (Q1) is -0.33.